Literature DB >> 23532604

[Medical University of Vienna Researcher of the Month of March 2013].

Christoph Grimm1.   

Abstract

Mesh：

Year:  2013        PMID： 23532604     DOI： 10.1007/s00508-013-0347-x

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  8 in total

1.  Treatment with vaginal progesterone in women with low-grade cervical dysplasia: a phase II trial.

Authors:  Lukas Hefler; Christoph Grimm; Clemens Tempfer; Alexander Reinthaller
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

2.  A novel training model for the loop electrosurgical excision procedure: an innovative replica helped workshop participants improve their LEEP.

Authors:  Lukas Hefler; Christoph Grimm; Verena Kueronya; Clemens Tempfer; Alexander Reinthaller; Stephan Polterauer
Journal:  Am J Obstet Gynecol       Date:  2012-01-13       Impact factor: 8.661

3.  The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial.

Authors:  Lukas A Hefler; Christoph Grimm; Paul Speiser; Gerhard Sliutz; Alexander Reinthaller
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-09-26       Impact factor: 2.435

4.  Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.

Authors:  Christoph Grimm; Rafal Watrowski; Konstantin Baumühlner; Camilla Natter; Dan Tong; Andrea Wolf; Robert Zeillinger; Sepp Leodolter; Alexander Reinthaller; Lukas Hefler
Journal:  Gynecol Oncol       Date:  2011-03-03       Impact factor: 5.482

5.  Vascular endothelial growth factor gene polymorphisms and risk of cervical intraepithelial neoplasia.

Authors:  Christoph Grimm; Rafal Watrowski; Stephan Polterauer; Konstantin Baumühlner; Camilla Natter; Jasmin Rahhal; Georg Heinze; Eva Schuster; Lukas Hefler; Alexander Reinthaller
Journal:  Int J Gynecol Cancer       Date:  2011-05       Impact factor: 3.437

6.  Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.

Authors:  Christoph Grimm; Stephan Polterauer; Camilla Natter; Jasmin Rahhal; Lukas Hefler; Clemens B Tempfer; Georg Heinze; Georg Stary; Alexander Reinthaller; Paul Speiser
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

7.  Nomogram prediction for overall survival of patients diagnosed with cervical cancer.

Authors:  S Polterauer; C Grimm; G Hofstetter; N Concin; C Natter; A Sturdza; R Pötter; C Marth; A Reinthaller; G Heinze
Journal:  Br J Cancer       Date:  2012-08-07       Impact factor: 7.640

8.  The impact of lymph node density on survival of cervical cancer patients.

Authors:  S Polterauer; L Hefler; V Seebacher; J Rahhal; C Tempfer; R Horvat; A Reinthaller; C Grimm
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.